Influence of ethanol extract of Ginkgo biloba leaves on the isolated rat heart work and mitochondria functions

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 5, 2012, Pages 450-457

  Baliutyte, Giedre ^a   Baniene, Rasa ^a   Gendviliene, Vida ^b   Martisiene, Irma ^b   Trumbeckaite, Sonata ^a   Borutaite, Vilmante ^a   Toleikis, Adolfas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

heart ischemia reperfusion; heart work; mitochondria respiration; NADH fluorescence

Indexed keywords

GINKGO BILOBA EXTRACT; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAM; FLUORESCENCE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; HEART WORK; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION; PLANT LEAF; PRIORITY JOURNAL; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FLUORESCENCE; GINKGO BILOBA; HEART RATE; HYDROGEN PEROXIDE; MALATES; MALE; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NAD; OXIDATION-REDUCTION; PLANT EXTRACTS; PLANT LEAVES; PYRUVIC ACID; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84861097191     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318249171d     Document Type: Article

References (59)

1. Pietri S, Maurelli E, Drieu K, et al. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol. 1997;29:733-742.
2. McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med. 2001;7:70-90.
3. Zhou W, Chai H, Lin PH, et al. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovasc Drug Rev. 2004;22:309-319.
4. Christen Y. Ginkgo biloba and neurodegenerative disorders. Front Biosci. 2004;9:3091-3104.
5. Eckert A, Keil U, Kressmann S, et al. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry. 2003;36(suppl 1):S15-S23.
6. Kusmic C, Basta G, Lazzerini G, et al. The effect of Ginkgo biloba in isolated ischemic/reperfused rat heart: a link between vitamin E preservation and prostaglandin biosynthesis. J Cardiovasc Pharmacol. 2004;44:356-362.
7. Bastianetto S, Zheng WH, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem. 2000;74:2268-2277.
8. DeFeudis FV, Papadopoulos V, Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol. 2003;17:405-417.
9. Smith JV, Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol. 2004;64:465-472.
10. Song W, Guan HJ, Zhu XZ, et al. Protective effect of bilobalide against nitric oxide-induced neurotoxicity in PC12 cells. Acta Pharmacol Sin. 2000;21:415-420.
11. Mahady GB. Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature. J Cardiovasc Nurs. 2002;16:21-32.
12. Eckert A, Keil U, Scherping I, et al. Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761. Ann N Y Acad Sci. 2005;1056:474-485.
13. Tendi EA, Bosetti F, Dasgupta SF, et al. Ginkgo biloba extracts EGb 761 and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells. Neurochem Res. 2002;27:319-323.
14. Trumbeckaite S, Bernatoniene J, Majiene D, et al. The effect of flavonoids on rat heart mitochondrial function. Biomed Pharmacother. 2006;60:245-248.
15. Trumbeckaite S, Bernatoniene J, Majiene D, et al. Effect of Ginkgo biloba extract on the rat heart mitochondrial function. J Ethnopharmacol. 2007;11:512-516.
16. Baliutyte G, Baniene R, Trumbeckaite S, et al. Effects of Ginkgo biloba extract on heart and liver mitochondrial functions: mechanism (s) of action. J Bioenerg Biomembr. 2010;42:165-172.
17. Krisciukaitis A, Minet O, Tamosiunas M, et al. Heart tissue viability monitoring in vivo by using combined fluorescence, thermography and electrical activity measurements. Biomed Tech (Berl). 2005;50:419-425.
18. Eng J, Lynch RM, Balaban RS. Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated cardiac myocytes. Biophys J. 1989;55:621-630.
19. Mayevsky A, Rogatsky GG. Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies. Am J Physiol Cell Physiol. 2007;292:C615-C640.
20. Satoh H, Nishida S. Electropharmacological actions of Ginkgo biloba extract on vascular smooth and heart muscles. Clin Chim Acta. 2004;342:13-22.
21. Satoh H. Effects of Ginkgo biloba extract and bilobalide, a main constituent, on the ionic currents in guinea pig ventricular cardiomyocytes. Arzneimittelforschung. 2003;53:407-413.
22. Satoh H. Suppression of pacemaker activity by Ginkgo biloba extract and its main constituent, bilobalide in rat sino-atrial nodal cells. Life Sci. 2005;78:67-73.
23. Chen B, Cai J, Song LS, et al. Effects of Ginkgo biloba extract on cation currents in rat ventricular myocytes. Life Sci. 2005;76:1111-1121.
24. Kim J, Li Q, Fang CX, et al. Paradoxical effects of ginkgolide B on cardiomyocyte contractile function in normal and high-glucose environments. Acta Pharmacol Sin. 2006;27:536-542.
25. Minet O, Beuthan J, Mildaziene V, et al. Fluorescence techniques in biomedicine: from the monitorin of cell metabolism to image processing in cancer detection. Am Rev Fluoresc. 2004;1:195-219.
26. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 1949;177:751-766.
27. Nishida S, Satoh H. Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta. Life Sci. 2003;72:2659-2667.
28. Katz AM. Physiology of the Heart. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:517-552.
29. Bers DM. Sarcoplasmic reticulum Ca release in intact ventricular myocytes. Front Biosci. 2002;7:d1697-d1711.
30. Losito VA, Tsushima RG, Diaz RJ, et al. Preferential regulation of rabbit cardiac L-type Ca2+ current by glycolytic derived ATP via a direct allosteric pathway. J Physiol. 1998;511(pt 1):67-78.
31. Yazawa K, Kameyama A, Yasui K, et al. ATP regulates cardiac Ca2+ channel activity via a mechanism independent of protein phosphorylation. Pflugers Arch. 1997;433:557-562.
32. Fukumoto GH, Lamp ST, Motter C, et al. Metabolic inhibition alters subcellular calcium release patterns in rat ventricular myocytes: implications for defective excitation-contraction coupling during cardiac ischemia and failure. Circ Res. 2005;96:551-557.
33. Maack C, O'Rourke B. Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol. 2007;102:369-392.
34. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129.
35. Marin-Garcia J, Goldenthal MJ, Moe GW. Mitochondrial pathology in cardiac failure. Cardiovasc Res. 2001;49:17-26.
36. Zablockaite D, Gendviliene V, Martisiene I, et al. Effect of oxidative phosphorylation uncoupler FCCP on the electromechanical activity of rat and human myocardium. Lit J Cardiol. 2005;12:55-59.
37. Zablockaite D, Gendviliene V, Martisiene I, et al. Effect of oxidative phosphorylation uncoupler FCCP and F1F0-ATPase inhibitor oligomycin on the electromechanical activity of human myocardium. Adv Med Sci. 2007;52:89-93.
38. Brandes R, Bers DM. Increased work in cardiac trabeculae causes decreased mitochondrial NADH fluorescence followed by slow recovery. Biophys J. 1996;71:1024-1035.
39. Chance B, Schoener B, Oshino R, et al. Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. J Biol Chem. 1979;254:4764-4771.
40. Ashruf JF, Coremans JM, Bruining HA, et al. Increase of cardiac work is associated with decrease of mitochondrial NADH. Am J Physiol. 1995;269(pt 2):H856-H862.
41. Fiorani M, Guidarelli A, Blasa M, et al. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J Nutr Biochem. 2010;21:397-404.
42. Toleikis A, Trumbeckaite S, Majiene D. Cytochrome C effect on respiration of heart mitochondria: influence of various factors. Biosci Rep. 2005;25:387-397.
43. Liebgott T, Miollan M, Berchadsky Y, et al. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res Cardiol. 2000;95:368-377.
44. Borutaite V, Morkuniene R, Budriunaite A, et al. Kinetic analysis of changes in activity of heart mitochondrial oxidative phosphorylation system induced by ischemia. J Mol Cell Cardiol. 1996;28:2195-2201.
45. Skulachev VP. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta. 1998;1363:100-124.
46. Miwa S, Brand MD. Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling. Biochem Soc Trans. 2003;31(pt 6):1300-1301.
47. Sack MN. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res. 2006;72:210-219.
48. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta. 2007;1767:1007-1031.
49. Song Y, Shryock JC, Wagner S, et al. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther. 2006;318:214-222.
50. Wang L, Lopaschuk GD, Clanachan AS. H (2) O (2)-induced left ventricular dysfunction in isolated working rat hearts is independent of calcium accumulation. J Mol Cell Cardiol. 2008;45:787-795.
51. Morita N, Sovari AA, Xie Y, et al. Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am J Physiol Heart Circ Physiol. 2009;297:H1594-H1605.
52. Brown GC, Borutaite V. There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion. 2011. http://dx.doi.org/10.1016/j.mito.2011.02.001. Accessed April 2012.
53. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. 2004;36:838-849.
54. MacLennan KM, Darlington CL, Smith PF. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol. 2002;67:235-257.
55. Le Poncin Lafitte M, Rapin J, Rapin JR. Effects of Ginkgo Biloba on changes induced by quantitative cerebral microembolization in rats. Arch Int Pharmacodyn Ther. 1980;243:236-244.
56. Mozet C, Martin R, Welt K, et al. Cardioprotective effect of EGb 761 on myocardial ultrastructure of young and old rat heart and antioxidant status during acute hypoxia. Aging Clin Exp Res. 2009;21:14-21.
57. Sastre J, Millán A, García de la Asunción J, et al. Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. Free Radic Biol Med. 1998;24:298-304.
58. Kim SY, Kwak JS, Shin JP, et al. The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina. Ophthalmologica. 1998;212:268-274.
59. Chan PC, Xia Q, Fu PP. Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007;25:211-244.